Document Detail

Toxic epidermal necrolysis.
MedLine Citation:
PMID:  17224365     Owner:  NLM     Status:  MEDLINE    
LEARNING OBJECTIVES: At the conclusion of this learning activity, participants should have acquired a more comprehensive knowledge of our current understanding of the classification, clinical presentation, etiology, pathophysiology, prognosis, and treatment of TEN.
Frederick A Pereira; Adarsh Vijay Mudgil; David M Rosmarin
Related Documents :
18201945 - Bayesian design and conduct of phase ii single-arm clinical trials with binary outcomes...
15911465 - Design and analysis of trials with rare outcomes: examples from trials in herpes transm...
2697015 - Ensuring data quality in a multicenter clinical trial: remote site data entry, central ...
22231275 - Predictors of ethylene glycol ingestion cases called into a regional poison center.
19397385 - Testing signal-detection models of yes/no and two-alternative forced-choice recognition...
21356565 - Development of an internet based system for modeling biotin metabolism using bayesian n...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of the American Academy of Dermatology     Volume:  56     ISSN:  1097-6787     ISO Abbreviation:  J. Am. Acad. Dermatol.     Publication Date:  2007 Feb 
Date Detail:
Created Date:  2007-01-16     Completed Date:  2007-02-06     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  7907132     Medline TA:  J Am Acad Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  181-200     Citation Subset:  IM    
Department of Dermatology, Mount Sinai School of Medicine, New York, New York, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Apoptosis / physiology
Diagnosis, Differential
Epidermal Necrolysis, Toxic* / diagnosis,  genetics,  physiopathology,  therapy
Fas Ligand Protein / genetics
Immunoglobulins, Intravenous / therapeutic use
Keratinocytes / immunology
Lymphocyte Activation / physiology
Polymorphism, Genetic
T-Lymphocytes / physiology
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Reg. No./Substance:
0/Fas Ligand Protein; 0/Immunoglobulins, Intravenous; 0/Tumor Necrosis Factor-alpha

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Resolution of symptoms of chronic constipation in an 8-year-old male after chiropractic treatment.
Next Document:  Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopi...